ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665076 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665076; 2) Community: the network communities that were significantly associated with the response to NSC 665076; 3) Molecule: the relationships between components within communities and NSC 665076; 4) MDR: the compounds that were significantly associated with the NSC 665076.

NSC Compound Enrichment Correlation
NSC 756166 GSK312948A 0.0467178916101845 0.15561626
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0467178916101845 0.3914224
NSC 96996 B 169 0.0467178916101845 0.4200582
NSC 106995 U 24792 0.0483128986658395 0.02708167
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0483128986658395 0.79482494
NSC 163443 Null 0.0490935610249065 0.067114993
NSC 659610 Null 0.0490935610249065 0.2862254
NSC 665771 Null 0.0490935610249068 0.063015512
NSC 668264 Null 0.0490935610249068 0.76189128
NSC 679822 Naphth[2,3-d]oxazol-9(4H)-one, 2-methyl- 4-[4-(4-morpholinyl)phenylimino]- 0.0490935610249068 0.32178241
Total:91  Current:88    [First] [Prev] [Next] [Last]